Recently, it was reported that ATF4 and phosphorylated (p) tauThr212/Ser214 levels were reduced in rTg4510 tauopathy mice by chronic administration of trazodone (40 mg/kg/d corresponding to 194 mg/d in humans (Halliday et al., 2017). This evidence concerns the gene ATF4 and tauopathy.